A detailed history of United Capital Management Of Ks, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, United Capital Management Of Ks, Inc. holds 24,550 shares of ABBV stock, worth $4.31 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares
24,550
Previous 28,512 13.9%
Holding current value
$4.31 Million
Previous $4.89 Million 0.86%
% of portfolio
1.2%
Previous 1.17%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$163.84 - $199.33 $649,134 - $789,745
-3,962 Reduced 13.9%
24,550 $4.85 Million
Q2 2024

Jul 30, 2024

BUY
$154.79 - $180.76 $26,623 - $31,090
172 Added 0.61%
28,512 $4.89 Million
Q1 2024

Apr 19, 2024

SELL
$159.82 - $182.1 $136,326 - $155,331
-853 Reduced 2.92%
28,340 $5.16 Million
Q4 2023

Jan 25, 2024

BUY
$137.6 - $154.97 $138,563 - $156,054
1,007 Added 3.57%
29,193 $4.52 Million
Q3 2023

Nov 03, 2023

BUY
$133.59 - $154.65 $7,347 - $8,505
55 Added 0.2%
28,186 $4.2 Million
Q2 2023

Aug 04, 2023

BUY
$132.51 - $164.9 $695,014 - $864,900
5,245 Added 22.92%
28,131 $3.79 Million
Q1 2023

Apr 27, 2023

BUY
$144.61 - $166.54 $140,416 - $161,710
971 Added 4.43%
22,886 $3.65 Million
Q4 2022

Jan 31, 2023

BUY
$138.31 - $165.87 $66,527 - $79,783
481 Added 2.24%
21,915 $3.54 Million
Q3 2022

Oct 31, 2022

BUY
$134.21 - $153.93 $32,210 - $36,943
240 Added 1.13%
21,434 $2.88 Million
Q2 2022

Aug 04, 2022

SELL
$137.62 - $174.96 $775,488 - $985,899
-5,635 Reduced 21.0%
21,194 $3.25 Million
Q1 2022

Apr 26, 2022

SELL
$131.98 - $163.75 $52,528 - $65,172
-398 Reduced 1.46%
26,829 $4.35 Million
Q4 2021

Jan 18, 2022

BUY
$107.43 - $135.93 $71,440 - $90,393
665 Added 2.5%
27,227 $3.69 Million
Q3 2021

Oct 27, 2021

BUY
$106.4 - $120.78 $34,473 - $39,132
324 Added 1.23%
26,562 $2.87 Million
Q2 2021

Jul 26, 2021

BUY
$105.21 - $117.21 $103,105 - $114,865
980 Added 3.88%
26,238 $2.96 Million
Q1 2021

Apr 27, 2021

BUY
$102.3 - $112.62 $109,972 - $121,066
1,075 Added 4.45%
25,258 $2.7 Million
Q4 2020

Jan 21, 2021

BUY
$80.49 - $108.67 $120,091 - $162,135
1,492 Added 6.58%
24,183 $2.59 Million
Q3 2020

Oct 19, 2020

BUY
$85.91 - $100.83 $84,793 - $99,519
987 Added 4.55%
22,691 $1.99 Million
Q2 2020

Jul 17, 2020

BUY
$73.37 - $98.18 $209,838 - $280,794
2,860 Added 15.18%
21,704 $2.13 Million
Q1 2020

May 04, 2020

BUY
$64.5 - $97.79 $94,041 - $142,577
1,458 Added 8.39%
18,844 $1.44 Million
Q4 2019

Jan 24, 2020

BUY
$72.13 - $90.25 $100,188 - $125,357
1,389 Added 8.68%
17,386 $1.54 Million
Q3 2019

Oct 15, 2019

BUY
$62.98 - $75.72 $71,986 - $86,547
1,143 Added 7.69%
15,997 $1.19 Million
Q2 2019

Jul 25, 2019

BUY
$65.7 - $83.98 $23,520 - $30,064
358 Added 2.47%
14,854 $1.09 Million
Q1 2019

May 01, 2019

BUY
$77.14 - $90.79 $99,279 - $116,846
1,287 Added 9.74%
14,496 $1.14 Million
Q4 2018

Jan 10, 2019

BUY
$77.85 - $96.01 $84,778 - $104,554
1,089 Added 8.99%
13,209 $1.22 Million
Q3 2018

Oct 09, 2018

BUY
$88.91 - $98.84 $1.08 Million - $1.2 Million
12,120 New
12,120 $1.1 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track United Capital Management Of Ks, Inc. Portfolio

Follow United Capital Management Of Ks, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Management Of Ks, Inc., based on Form 13F filings with the SEC.

News

Stay updated on United Capital Management Of Ks, Inc. with notifications on news.